Last reviewed · How we verify
NCT04253002
Preventing Suicide in African American Adolescents
NA trial testing Robinson's Culturally Adapted Coping with Stress Course (A-CWS) in Suicide in 512 participants. Participants enrolled and being followed up; not accepting new ones.
30 June 2026
Quick facts
| Lead sponsor | DePaul University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 512 |
| Start date | 1 February 2022 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 6 locations across United States |
Drugs / interventions tested
- Robinson's Culturally Adapted Coping with Stress Course (A-CWS)
- Standard Care Control Condition
Conditions studied
- Suicide — all drugs for Suicide →
Sponsor
DePaul University
Who can join
12 and older, any sex, with Suicide. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overarching aim of the Success Over Stress Prevention Project is to reduce African American youth suicide. This study examines the impact of a 15-session, group-delivered, culturally-grounded, cognitive-behavioral intervention (i.e., PI Robinson's Adapted-Coping with Stress Course \[A-CWS\]), on the outcomes of interest, when it is delivered by social workers who are indigenous to the school system. The main objectives of this project are to (a) determine whether the intervention is effective when facilitated by social workers who are indigenous to the school system and (b) enhance resilience, increase adaptive coping strategies, and reduce both intrapersonal and interpersonal violence among youth receiving the prevention intervention. It is expected that increases in adaptive coping will lead to an increased ability for youth to manage stressors, thereby decreasing the incidence of suicide and violence among the youth. In addition, it is expected that evidence of the intervention's effectiveness, when facilitated by social workers who are indigenous to the school system, will lead to greater dissemination and sustainability of the intervention, thus, providing access to effective intervention resources to greater numbers of African American youth.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prevention of self-harm and suicide in young people up to the age of 25 in education settings.
Sharma V, Marshall D, Fortune S, Prescott AE, et al · · 2024 · cited 5× · PMID 39704320 · DOI 10.1002/14651858.cd013844.pub2
Verify or expand the search:
- PubMed search for NCT04253002
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicide
Currently open trials in the same condition.
- NCT07404787 — Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Ho · NA · recruiting
- NCT07214233 — Youth Empowerment and Safety Intervention · NA · recruiting
- NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
- NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
- NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting
Other DePaul University trials
Trials by the same sponsor.
- NCT06071130 — Emotion, Aging, and Decision Making · NA · not yet recruiting
- NCT03954457 — Social Ecology and the Prevention of Suicide and Aggression in African American Youth · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04253002 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by DePaul University
- Last refreshed: 5 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04253002.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing